By the time AstraZeneca moved to buy the business in a $39 billion deal (€39.5 billion), Alexion employed about 500 people in the State, having invested more than €600 million at sites in ...

Covid-19 vaccine maker AstraZeneca has lodged plans for a $360 million (€337 million) “next generation” active pharma ingredient-manufacturing facility for north Co Dublin.

Covid-19 vaccine maker AstraZeneca has lodged plans for a $360m (€340m) ‘next generation’ active pharma ingredient (API) manufacturing facility for north Dublin.

AstraZeneca announced plans last year for the construction of its first manufacturing plant in Ireland, with a $360M investment that AstraZeneca Executive Vice President, Operations and IT Pam ...

Covid-19 vaccine maker AstraZeneca has secured the green light for a $360m "next generation" active pharma ingredient (API) manufacturing facility for north Dublin.

AstraZeneca’s $39 billion buyout of Alexion was completed less than a y ... AZ revealed it was laying out $360 million for a next-generation manufacturing plant in Dublin.